91335-52-3

Basic information

• Product Name: 3-BROMO-5-METHOXY-4-PROPOXY-BENZALDEHYDE
• Synonyms: 3-Bromo-5-methoxy-4-propoxy-benzaldehyde; benzaldehyde, 3-bromo-5-methoxy-4-propoxy-
• CAS NO: 91335-52-3
• Molecular Formula: C₁₁H₁₃BrO₃
• Molecular Weight: 273.13
• Mol File: 91335-52-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 341.6°Cat760mmHg
• Flash Point: 160.4°C
• Appearance: /
• Density: 1.377g/cm³
• Vapor Pressure: 7.98E-05mmHg at 25°C
• Refractive Index: 1.551
• CAS DataBase Reference: 3-BROMO-5-METHOXY-4-PROPOXY-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-5-METHOXY-4-PROPOXY-BENZALDEHYDE(91335-52-3)
• EPA Substance Registry System: 3-BROMO-5-METHOXY-4-PROPOXY-BENZALDEHYDE(91335-52-3)

Safety Data

• Hazardous Substances Data: 91335-52-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H13BrO3/c1-3-4-15-11-9(12)5-8(7-13)6-10(11)14-2/h5-7H,3-4H2,1-2H3

Upstream product

• 2973-76-4 5-bromo-4-hydroxy-3-methoxybenzaldehyde 
• 106-94-5 propyl bromide 
• 107-08-4 1-iodo-propane 
• 121-33-5 vanillin 

Downstream Products

• 116754-25-7 3-methoxy-5-methylthio-4-propoxybenzyl alcohol 
• 1256244-56-0 (Z)-5-(3-bromo-5-methoxy-4-propoxybenzylidene)imidazolidine-2,4-dione 

Relevant articles and documents

Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study

In order to develop novel anti-cancer agents, a series of asymmetrical 2,6-bis (benzylidene)cyclohexanone derivatives containing nitrobenzylidene moiety were synthesized and their cytotoxic activity were determined in vitro against MDA-MB 231, MCF-7 and SK-N-MC cell lines using MTT assay. Among the tested compounds, the highest activity against MDA-MB 231 cells was achieved by 2-(3-bromo-5-methoxy-4-propoxybenzylidene)-6-(2-nitrobenzylidene)cyclohexanone (compound 5d). Whereas, compound 5j (the 3-nitro analog of compound 5d) was the most potent compound against MCF-7 and SK-N-MC cell lines. The results indicated that the cytotoxic activity profile against different tumor cells can be optimized by desired 4-alkoxy-3-bromo-5-methoxybenzylidene scaffold.

New 1,3-diaryl cyclopentanes and derivatives thereof as paf antagonists

Novel 1,3-Diaryl cyclopentanes were prepared. These compounds were found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities and as such useful in the treatment or amelioration of various diseases or disorders mediated by